

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | carnitine shuttle (GO:0006853) | 8.04007089 |
| 2 | regulation of sequestering of triglyceride (GO:0010889) | 7.80489247 |
| 3 | tricarboxylic acid cycle (GO:0006099) | 7.35500509 |
| 4 | fatty acid transmembrane transport (GO:1902001) | 7.25248499 |
| 5 | carnitine transmembrane transport (GO:1902603) | 6.15433927 |
| 6 | * regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.91477755 |
| 7 | muscle filament sliding (GO:0030049) | 5.91081797 |
| 8 | actin-myosin filament sliding (GO:0033275) | 5.91081797 |
| 9 | NADH metabolic process (GO:0006734) | 5.71632659 |
| 10 | carnitine transport (GO:0015879) | 5.68356011 |
| 11 | amino-acid betaine transport (GO:0015838) | 5.68356011 |
| 12 | fatty acid beta-oxidation (GO:0006635) | 5.59498734 |
| 13 | regulation of skeletal muscle contraction (GO:0014819) | 5.39484270 |
| 14 | * regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.35606357 |
| 15 | sarcomere organization (GO:0045214) | 5.33007535 |
| 16 | biotin metabolic process (GO:0006768) | 5.10918447 |
| 17 | actin-mediated cell contraction (GO:0070252) | 4.93826217 |
| 18 | * regulation of cofactor metabolic process (GO:0051193) | 4.85148574 |
| 19 | * regulation of coenzyme metabolic process (GO:0051196) | 4.85148574 |
| 20 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.82270910 |
| 21 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.82069323 |
| 22 | * regulation of fatty acid oxidation (GO:0046320) | 4.81676245 |
| 23 | positive regulation of fatty acid oxidation (GO:0046321) | 4.78965471 |
| 24 | fatty acid catabolic process (GO:0009062) | 4.69932868 |
| 25 | fatty acid oxidation (GO:0019395) | 4.63267928 |
| 26 | lipid oxidation (GO:0034440) | 4.55903659 |
| 27 | myofibril assembly (GO:0030239) | 4.52141655 |
| 28 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.51081593 |
| 29 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.49449947 |
| 30 | plasma membrane repair (GO:0001778) | 4.47456444 |
| 31 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.37058579 |
| 32 | succinate metabolic process (GO:0006105) | 4.36643616 |
| 33 | intracellular lipid transport (GO:0032365) | 4.30060596 |
| 34 | cardiac myofibril assembly (GO:0055003) | 4.28375057 |
| 35 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.23683709 |
| 36 | branched-chain amino acid catabolic process (GO:0009083) | 4.21312288 |
| 37 | acetyl-CoA metabolic process (GO:0006084) | 4.19878657 |
| 38 | quaternary ammonium group transport (GO:0015697) | 4.18638621 |
| 39 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.17640754 |
| 40 | respiratory electron transport chain (GO:0022904) | 4.16783092 |
| 41 | response to epinephrine (GO:0071871) | 4.13019505 |
| 42 | lipid particle organization (GO:0034389) | 4.06095814 |
| 43 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.04213187 |
| 44 | electron transport chain (GO:0022900) | 4.04197138 |
| 45 | skeletal muscle contraction (GO:0003009) | 4.03865888 |
| 46 | creatine metabolic process (GO:0006600) | 4.03802354 |
| 47 | skeletal muscle adaptation (GO:0043501) | 3.94513246 |
| 48 | tricarboxylic acid metabolic process (GO:0072350) | 3.89468016 |
| 49 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.87767689 |
| 50 | regulation of relaxation of muscle (GO:1901077) | 3.86090340 |
| 51 | lysine catabolic process (GO:0006554) | 3.85758869 |
| 52 | lysine metabolic process (GO:0006553) | 3.85758869 |
| 53 | * regulation of sulfur metabolic process (GO:0042762) | 3.85234007 |
| 54 | brown fat cell differentiation (GO:0050873) | 3.85026393 |
| 55 | regulation of cell communication by electrical coupling (GO:0010649) | 3.82189010 |
| 56 | branched-chain amino acid metabolic process (GO:0009081) | 3.81331920 |
| 57 | 2-oxoglutarate metabolic process (GO:0006103) | 3.79451429 |
| 58 | valine metabolic process (GO:0006573) | 3.78749406 |
| 59 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.74310414 |
| 60 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.71492931 |
| 61 | actin filament-based movement (GO:0030048) | 3.71078809 |
| 62 | striated muscle contraction (GO:0006941) | 3.66505156 |
| 63 | monocarboxylic acid catabolic process (GO:0072329) | 3.63951868 |
| 64 | acyl-CoA biosynthetic process (GO:0071616) | 3.63532622 |
| 65 | thioester biosynthetic process (GO:0035384) | 3.63532622 |
| 66 | regulation of actin filament-based movement (GO:1903115) | 3.62095933 |
| 67 | cardiac muscle contraction (GO:0060048) | 3.61288874 |
| 68 | detection of calcium ion (GO:0005513) | 3.60395182 |
| 69 | positive regulation of lipid storage (GO:0010884) | 3.51805439 |
| 70 | short-chain fatty acid metabolic process (GO:0046459) | 3.50836269 |
| 71 | cardiolipin metabolic process (GO:0032048) | 3.47990010 |
| 72 | actomyosin structure organization (GO:0031032) | 3.43469469 |
| 73 | oxidative phosphorylation (GO:0006119) | 3.43147488 |
| 74 | cardiac muscle hypertrophy (GO:0003300) | 3.42283111 |
| 75 | aspartate family amino acid catabolic process (GO:0009068) | 3.40445286 |
| 76 | carnitine metabolic process (GO:0009437) | 3.37583565 |
| 77 | cellular response to epinephrine stimulus (GO:0071872) | 3.37107086 |
| 78 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.34235349 |
| 79 | triglyceride catabolic process (GO:0019433) | 3.33265496 |
| 80 | striated muscle hypertrophy (GO:0014897) | 3.31914829 |
| 81 | glycogen biosynthetic process (GO:0005978) | 3.31595552 |
| 82 | glucan biosynthetic process (GO:0009250) | 3.31595552 |
| 83 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.26912069 |
| 84 | ethanol oxidation (GO:0006069) | 3.25689090 |
| 85 | cardiac muscle cell development (GO:0055013) | 3.23018601 |
| 86 | glycogen catabolic process (GO:0005980) | 3.20264218 |
| 87 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.19803674 |
| 88 | negative regulation of complement activation (GO:0045916) | 3.19391299 |
| 89 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.18906797 |
| 90 | regulation of triglyceride catabolic process (GO:0010896) | 3.11383559 |
| 91 | regulation of striated muscle contraction (GO:0006942) | 3.10051795 |
| 92 | quinone biosynthetic process (GO:1901663) | 3.09337368 |
| 93 | ubiquinone biosynthetic process (GO:0006744) | 3.09337368 |
| 94 | long-chain fatty acid transport (GO:0015909) | 3.08905285 |
| 95 | heart trabecula formation (GO:0060347) | 3.08107180 |
| 96 | macroautophagy (GO:0016236) | 3.05952724 |
| 97 | muscle hypertrophy (GO:0014896) | 3.05565890 |
| 98 | striated muscle atrophy (GO:0014891) | 3.04676545 |
| 99 | cGMP-mediated signaling (GO:0019934) | 3.03868572 |
| 100 | cardiac cell development (GO:0055006) | 3.02059189 |
| 101 | glucan catabolic process (GO:0009251) | 3.01380033 |
| 102 | adult heart development (GO:0007512) | 3.00321153 |
| 103 | acylglycerol catabolic process (GO:0046464) | 2.99245324 |
| 104 | neutral lipid catabolic process (GO:0046461) | 2.99245324 |
| 105 | cellular ketone body metabolic process (GO:0046950) | 2.98533029 |
| 106 | muscle contraction (GO:0006936) | 2.97991449 |
| 107 | fatty acid homeostasis (GO:0055089) | 2.97971637 |
| 108 | transcytosis (GO:0045056) | 2.96799646 |
| 109 | heart contraction (GO:0060047) | 2.95460790 |
| 110 | heart process (GO:0003015) | 2.95460790 |
| 111 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.93847112 |
| 112 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.93756579 |
| 113 | negative regulation of protein activation cascade (GO:2000258) | 2.93063318 |
| 114 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.91137003 |
| 115 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.91036480 |
| 116 | regulation of sarcomere organization (GO:0060297) | 2.90515165 |
| 117 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.88442369 |
| 118 | potassium ion export (GO:0071435) | 2.88226130 |
| 119 | lipid storage (GO:0019915) | 2.87348379 |
| 120 | positive regulation of gluconeogenesis (GO:0045722) | 2.86934685 |
| 121 | regulation of energy homeostasis (GO:2000505) | 2.86463018 |
| 122 | oxaloacetate metabolic process (GO:0006107) | 2.84159749 |
| 123 | regulation of the force of heart contraction (GO:0002026) | 2.83994390 |
| 124 | regulation of membrane repolarization (GO:0060306) | 2.80818274 |
| 125 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.75845460 |
| 126 | response to catecholamine (GO:0071869) | 2.75014094 |
| 127 | response to monoamine (GO:0071867) | 2.75014094 |
| 128 | ketone body metabolic process (GO:1902224) | 2.74736392 |
| 129 | peptide hormone processing (GO:0016486) | 2.69408068 |
| 130 | regulation of lipoprotein metabolic process (GO:0050746) | 2.68489389 |
| 131 | response to inactivity (GO:0014854) | 2.67478095 |
| 132 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.65546622 |
| 133 | phospholipid homeostasis (GO:0055091) | 2.64353886 |
| 134 | cardiac muscle adaptation (GO:0014887) | 2.62160666 |
| 135 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.62160666 |
| 136 | muscle hypertrophy in response to stress (GO:0003299) | 2.62160666 |
| 137 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.61159398 |
| 138 | relaxation of cardiac muscle (GO:0055119) | 2.61091190 |
| 139 | toxin metabolic process (GO:0009404) | 2.60387928 |
| 140 | cell communication involved in cardiac conduction (GO:0086065) | 2.59453991 |
| 141 | ethanol metabolic process (GO:0006067) | 2.55549671 |
| 142 | muscle system process (GO:0003012) | 2.54260742 |
| 143 | regulation of heart rate (GO:0002027) | 2.53598569 |
| 144 | cardiac muscle cell action potential (GO:0086001) | 2.52250250 |
| 145 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.50353835 |
| 146 | cellular polysaccharide catabolic process (GO:0044247) | 2.49715741 |
| 147 | epoxygenase P450 pathway (GO:0019373) | 2.48664271 |
| 148 | regulation of cardiac muscle contraction (GO:0055117) | 2.47409062 |
| 149 | muscle tissue morphogenesis (GO:0060415) | 2.46988562 |
| 150 | striated muscle adaptation (GO:0014888) | 2.46772582 |
| 151 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.46567303 |
| 152 | adrenergic receptor signaling pathway (GO:0071875) | 2.45769166 |
| 153 | positive regulation of heart rate (GO:0010460) | 2.44876962 |
| 154 | cardiac conduction (GO:0061337) | 2.44615267 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 9.86722150 |
| 2 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 5.25704525 |
| 3 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.98050898 |
| 4 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.73102090 |
| 5 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.64198866 |
| 6 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.57885615 |
| 7 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.45030105 |
| 8 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.37725586 |
| 9 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.35614136 |
| 10 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.35614136 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.27808557 |
| 12 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.17821198 |
| 13 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.05063007 |
| 14 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.02271209 |
| 15 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.00026848 |
| 16 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.98847086 |
| 17 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.84954509 |
| 18 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.70945548 |
| 19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.70030664 |
| 20 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.65235368 |
| 21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.60874514 |
| 22 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.58542364 |
| 23 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.54685611 |
| 24 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.52836807 |
| 25 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.52806550 |
| 26 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.51283991 |
| 27 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.46369764 |
| 28 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.40728095 |
| 29 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.38775943 |
| 30 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.38154358 |
| 31 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.37464147 |
| 32 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.33602401 |
| 33 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.33300966 |
| 34 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.31779330 |
| 35 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.30959947 |
| 36 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.28525716 |
| 37 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.28441446 |
| 38 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.28146519 |
| 39 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.20705514 |
| 40 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.18923417 |
| 41 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.17992501 |
| 42 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.12877829 |
| 43 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.12460083 |
| 44 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.11684801 |
| 45 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.11684801 |
| 46 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.11563951 |
| 47 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.11343079 |
| 48 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.09979020 |
| 49 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.07310683 |
| 50 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.07006477 |
| 51 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06968289 |
| 52 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.06817746 |
| 53 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.06817746 |
| 54 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03387155 |
| 55 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.03299691 |
| 56 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.03241545 |
| 57 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.02679385 |
| 58 | CJUN_26792858_Chip-Seq_BT549_Human | 1.01191135 |
| 59 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.99758718 |
| 60 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.99255322 |
| 61 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.99233989 |
| 62 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.98649258 |
| 63 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98329350 |
| 64 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.97624620 |
| 65 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.97494364 |
| 66 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97168106 |
| 67 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.96771763 |
| 68 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.96648431 |
| 69 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.96318347 |
| 70 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.96302298 |
| 71 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.96019915 |
| 72 | STAT3_23295773_ChIP-Seq_U87_Human | 0.94490068 |
| 73 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.94206546 |
| 74 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.93744803 |
| 75 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.93444866 |
| 76 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.93174835 |
| 77 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.93154475 |
| 78 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.93031427 |
| 79 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.92937436 |
| 80 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.92901259 |
| 81 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.91385319 |
| 82 | TCF4_23295773_ChIP-Seq_U87_Human | 0.91152466 |
| 83 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.89566861 |
| 84 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.89090636 |
| 85 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.88946523 |
| 86 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.88304333 |
| 87 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.87632773 |
| 88 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.87447576 |
| 89 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87438356 |
| 90 | TBL1_22424771_ChIP-Seq_293T_Human | 0.87049302 |
| 91 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.86599148 |
| 92 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.86586674 |
| 93 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.85718900 |
| 94 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.85626301 |
| 95 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.85398775 |
| 96 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.85302529 |
| 97 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.85185693 |
| 98 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.85004734 |
| 99 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.84889759 |
| 100 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.83841520 |
| 101 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.83627067 |
| 102 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83515291 |
| 103 | RXR_22108803_ChIP-Seq_LS180_Human | 0.83497656 |
| 104 | * AR_25329375_ChIP-Seq_VCAP_Human | 0.82951751 |
| 105 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.82018443 |
| 106 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.81745680 |
| 107 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.81647599 |
| 108 | GATA1_19941826_ChIP-Seq_K562_Human | 0.81309568 |
| 109 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.79902435 |
| 110 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.78755112 |
| 111 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.78739707 |
| 112 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.78739707 |
| 113 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.77420266 |
| 114 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.77196071 |
| 115 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76066144 |
| 116 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.74934583 |
| 117 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.74749512 |
| 118 | GATA1_22025678_ChIP-Seq_K562_Human | 0.74509042 |
| 119 | VDR_22108803_ChIP-Seq_LS180_Human | 0.74456191 |
| 120 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.74180700 |
| 121 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.74069766 |
| 122 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.74041899 |
| 123 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.73597208 |
| 124 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.73516554 |
| 125 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.73406301 |
| 126 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.73379463 |
| 127 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.72852012 |
| 128 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.72572598 |
| 129 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.71563155 |
| 130 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.71424637 |
| 131 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.71355724 |
| 132 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.71244726 |
| 133 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.70719217 |
| 134 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.69907744 |
| 135 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.69666577 |
| 136 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.69432580 |
| 137 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.67163961 |
| 138 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.66353478 |
| 139 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.66311817 |
| 140 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.66077319 |
| 141 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.65830146 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 5.34710975 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 5.20559036 |
| 3 | MP0004130_abnormal_muscle_cell | 4.29446429 |
| 4 | MP0000751_myopathy | 4.25724939 |
| 5 | MP0005670_abnormal_white_adipose | 4.23126459 |
| 6 | MP0000749_muscle_degeneration | 3.81359564 |
| 7 | MP0005666_abnormal_adipose_tissue | 3.57742601 |
| 8 | MP0004036_abnormal_muscle_relaxation | 3.26004996 |
| 9 | MP0004145_abnormal_muscle_electrophysio | 3.19606872 |
| 10 | MP0004084_abnormal_cardiac_muscle | 3.17591520 |
| 11 | MP0005330_cardiomyopathy | 3.07695753 |
| 12 | MP0004185_abnormal_adipocyte_glucose | 3.02994846 |
| 13 | MP0004215_abnormal_myocardial_fiber | 2.95177613 |
| 14 | MP0004087_abnormal_muscle_fiber | 2.84506996 |
| 15 | MP0002971_abnormal_brown_adipose | 2.69522527 |
| 16 | MP0002139_abnormal_hepatobiliary_system | 2.67805679 |
| 17 | MP0005375_adipose_tissue_phenotype | 2.58672496 |
| 18 | MP0002106_abnormal_muscle_physiology | 2.56840789 |
| 19 | MP0006036_abnormal_mitochondrial_physio | 2.51144678 |
| 20 | MP0000750_abnormal_muscle_regeneration | 2.49600503 |
| 21 | MP0005620_abnormal_muscle_contractility | 2.48504736 |
| 22 | MP0000747_muscle_weakness | 2.34848772 |
| 23 | MP0000759_abnormal_skeletal_muscle | 2.32874435 |
| 24 | MP0002972_abnormal_cardiac_muscle | 2.20684499 |
| 25 | MP0000013_abnormal_adipose_tissue | 2.20662536 |
| 26 | MP0002269_muscular_atrophy | 2.18570825 |
| 27 | MP0005369_muscle_phenotype | 2.13603648 |
| 28 | MP0008775_abnormal_heart_ventricle | 2.07633809 |
| 29 | MP0004484_altered_response_of | 1.89561709 |
| 30 | MP0000003_abnormal_adipose_tissue | 1.89499362 |
| 31 | MP0001544_abnormal_cardiovascular_syste | 1.87399055 |
| 32 | MP0005385_cardiovascular_system_phenoty | 1.87399055 |
| 33 | MP0002876_abnormal_thyroid_physiology | 1.82683894 |
| 34 | MP0010630_abnormal_cardiac_muscle | 1.82476835 |
| 35 | MP0006138_congestive_heart_failure | 1.78137867 |
| 36 | MP0002332_abnormal_exercise_endurance | 1.75760406 |
| 37 | MP0003137_abnormal_impulse_conducting | 1.74221356 |
| 38 | MP0003221_abnormal_cardiomyocyte_apopto | 1.67885838 |
| 39 | MP0004233_abnormal_muscle_weight | 1.66531459 |
| 40 | MP0003950_abnormal_plasma_membrane | 1.65525091 |
| 41 | MP0005379_endocrine/exocrine_gland_phen | 1.63648670 |
| 42 | MP0008438_abnormal_cutaneous_collagen | 1.61427492 |
| 43 | MP0005535_abnormal_body_temperature | 1.57175383 |
| 44 | MP0003011_delayed_dark_adaptation | 1.41015407 |
| 45 | MP0003868_abnormal_feces_composition | 1.36853083 |
| 46 | MP0004043_abnormal_pH_regulation | 1.29899259 |
| 47 | MP0005334_abnormal_fat_pad | 1.29364437 |
| 48 | MP0004085_abnormal_heartbeat | 1.26292418 |
| 49 | MP0002108_abnormal_muscle_morphology | 1.25316570 |
| 50 | MP0004019_abnormal_vitamin_homeostasis | 1.22997032 |
| 51 | MP0010234_abnormal_vibrissa_follicle | 1.22876718 |
| 52 | MP0003828_pulmonary_edema | 1.20768373 |
| 53 | MP0003879_abnormal_hair_cell | 1.20601576 |
| 54 | * MP0002118_abnormal_lipid_homeostasis | 1.20520380 |
| 55 | MP0003195_calcinosis | 1.18240391 |
| 56 | MP0009115_abnormal_fat_cell | 1.16089593 |
| 57 | MP0005275_abnormal_skin_tensile | 1.14213488 |
| 58 | MP0002638_abnormal_pupillary_reflex | 1.13877451 |
| 59 | * MP0002078_abnormal_glucose_homeostasis | 1.13006137 |
| 60 | MP0002970_abnormal_white_adipose | 1.08176172 |
| 61 | MP0002254_reproductive_system_inflammat | 1.07601385 |
| 62 | MP0009840_abnormal_foam_cell | 1.07426474 |
| 63 | MP0006035_abnormal_mitochondrial_morpho | 1.06744331 |
| 64 | MP0001944_abnormal_pancreas_morphology | 1.05972526 |
| 65 | MP0002693_abnormal_pancreas_physiology | 1.04759178 |
| 66 | MP0000343_altered_response_to | 1.01386597 |
| 67 | MP0010329_abnormal_lipoprotein_level | 1.00289426 |
| 68 | MP0004270_analgesia | 0.98251787 |
| 69 | MP0000733_abnormal_muscle_development | 0.97741941 |
| 70 | MP0001501_abnormal_sleep_pattern | 0.95917316 |
| 71 | MP0008961_abnormal_basal_metabolism | 0.95064904 |
| 72 | MP0005645_abnormal_hypothalamus_physiol | 0.91544254 |
| 73 | MP0008004_abnormal_stomach_pH | 0.91482059 |
| 74 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.91159623 |
| 75 | MP0005452_abnormal_adipose_tissue | 0.88218422 |
| 76 | MP0000230_abnormal_systemic_arterial | 0.86509582 |
| 77 | MP0001661_extended_life_span | 0.84560031 |
| 78 | MP0001879_abnormal_lymphatic_vessel | 0.84007960 |
| 79 | MP0005448_abnormal_energy_balance | 0.81827116 |
| 80 | MP0003959_abnormal_lean_body | 0.79805216 |
| 81 | MP0001984_abnormal_olfaction | 0.79425257 |
| 82 | MP0005266_abnormal_metabolism | 0.79286185 |
| 83 | * MP0005332_abnormal_amino_acid | 0.77568689 |
| 84 | MP0005646_abnormal_pituitary_gland | 0.76598330 |
| 85 | MP0002127_abnormal_cardiovascular_syste | 0.76147415 |
| 86 | MP0004272_abnormal_basement_membrane | 0.75260347 |
| 87 | MP0010386_abnormal_urinary_bladder | 0.75020489 |
| 88 | MP0001765_abnormal_ion_homeostasis | 0.74810835 |
| 89 | MP0004510_myositis | 0.74283850 |
| 90 | MP0002295_abnormal_pulmonary_circulatio | 0.74114912 |
| 91 | MP0000266_abnormal_heart_morphology | 0.73608353 |
| 92 | MP0002234_abnormal_pharynx_morphology | 0.72813949 |
| 93 | MP0005636_abnormal_mineral_homeostasis | 0.71404397 |
| 94 | MP0005165_increased_susceptibility_to | 0.69282803 |
| 95 | MP0003279_aneurysm | 0.69117028 |
| 96 | MP0005167_abnormal_blood-brain_barrier | 0.65889708 |
| 97 | MP0005360_urolithiasis | 0.65499366 |
| 98 | MP0003806_abnormal_nucleotide_metabolis | 0.64622584 |
| 99 | MP0003690_abnormal_glial_cell | 0.64443155 |
| 100 | MP0002909_abnormal_adrenal_gland | 0.62671102 |
| 101 | MP0003045_fibrosis | 0.61628440 |
| 102 | MP0005319_abnormal_enzyme/_coenzyme | 0.61496155 |
| 103 | MP0005058_abnormal_lysosome_morphology | 0.61014786 |
| 104 | MP0003948_abnormal_gas_homeostasis | 0.59009761 |
| 105 | MP0003075_altered_response_to | 0.58451457 |
| 106 | MP0000609_abnormal_liver_physiology | 0.58384507 |
| 107 | MP0005409_darkened_coat_color | 0.57915189 |
| 108 | MP0003705_abnormal_hypodermis_morpholog | 0.57149066 |
| 109 | MP0004147_increased_porphyrin_level | 0.54324734 |
| 110 | MP0003567_abnormal_fetal_cardiomyocyte | 0.52510085 |
| 111 | MP0009780_abnormal_chondrocyte_physiolo | 0.51854868 |
| 112 | MP0001727_abnormal_embryo_implantation | 0.51797166 |
| 113 | MP0005365_abnormal_bile_salt | 0.51649510 |
| 114 | MP0003566_abnormal_cell_adhesion | 0.51355273 |
| 115 | MP0010368_abnormal_lymphatic_system | 0.49118473 |
| 116 | MP0005451_abnormal_body_composition | 0.45342328 |
| 117 | MP0009643_abnormal_urine_homeostasis | 0.43893432 |
| 118 | MP0002128_abnormal_blood_circulation | 0.43368393 |
| 119 | MP0005623_abnormal_meninges_morphology | 0.43210347 |
| 120 | MP0003191_abnormal_cellular_cholesterol | 0.39830623 |
| 121 | * MP0003953_abnormal_hormone_level | 0.38804210 |
| 122 | MP0001299_abnormal_eye_distance/ | 0.37116005 |
| 123 | MP0000920_abnormal_myelination | 0.36614119 |
| 124 | MP0002896_abnormal_bone_mineralization | 0.35283995 |
| 125 | MP0005085_abnormal_gallbladder_physiolo | 0.35001462 |
| 126 | MP0001958_emphysema | 0.34639823 |
| 127 | MP0005595_abnormal_vascular_smooth | 0.31052802 |
| 128 | MP0001756_abnormal_urination | 0.30469826 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 6.85273890 |
| 2 | Myoglobinuria (HP:0002913) | 6.46851771 |
| 3 | Exercise-induced muscle cramps (HP:0003710) | 5.33692299 |
| 4 | Rhabdomyolysis (HP:0003201) | 5.33263320 |
| 5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.13924270 |
| 6 | Muscle fiber splitting (HP:0003555) | 5.12395859 |
| 7 | Calf muscle hypertrophy (HP:0008981) | 5.11409702 |
| 8 | Muscle fiber inclusion bodies (HP:0100299) | 5.05051805 |
| 9 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.90246150 |
| 10 | Sudden death (HP:0001699) | 4.87320606 |
| 11 | Difficulty running (HP:0009046) | 4.86892756 |
| 12 | Hyporeflexia of lower limbs (HP:0002600) | 4.62375859 |
| 13 | Hypoglycemic coma (HP:0001325) | 4.40571428 |
| 14 | Nemaline bodies (HP:0003798) | 4.38690271 |
| 15 | Type 1 muscle fiber predominance (HP:0003803) | 4.37279380 |
| 16 | Increased connective tissue (HP:0009025) | 4.04658591 |
| 17 | Abnormality of the calf musculature (HP:0001430) | 3.98906470 |
| 18 | Muscle stiffness (HP:0003552) | 3.94705140 |
| 19 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.89030507 |
| 20 | Ventricular tachycardia (HP:0004756) | 3.77382186 |
| 21 | Dicarboxylic aciduria (HP:0003215) | 3.70745863 |
| 22 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.70745863 |
| 23 | Hyperglycinuria (HP:0003108) | 3.62349385 |
| 24 | EMG: myopathic abnormalities (HP:0003458) | 3.55971175 |
| 25 | Hepatic necrosis (HP:0002605) | 3.53120365 |
| 26 | Increased muscle lipid content (HP:0009058) | 3.44257391 |
| 27 | Ketoacidosis (HP:0001993) | 3.37181683 |
| 28 | Lipoatrophy (HP:0100578) | 3.34459501 |
| 29 | Distal arthrogryposis (HP:0005684) | 3.33619210 |
| 30 | Ventricular fibrillation (HP:0001663) | 3.33266051 |
| 31 | Subaortic stenosis (HP:0001682) | 3.32648342 |
| 32 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.32648342 |
| 33 | Atrial fibrillation (HP:0005110) | 3.10183795 |
| 34 | Dilated cardiomyopathy (HP:0001644) | 3.09418650 |
| 35 | Myotonia (HP:0002486) | 3.06268562 |
| 36 | Palpitations (HP:0001962) | 3.02182887 |
| 37 | Increased variability in muscle fiber diameter (HP:0003557) | 3.02041039 |
| 38 | Asymmetric septal hypertrophy (HP:0001670) | 3.01759916 |
| 39 | Round ear (HP:0100830) | 2.99721694 |
| 40 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.96630193 |
| 41 | Abnormality of glycine metabolism (HP:0010895) | 2.96630193 |
| 42 | Generalized aminoaciduria (HP:0002909) | 2.90673885 |
| 43 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.89787247 |
| 44 | Right ventricular cardiomyopathy (HP:0011663) | 2.88067674 |
| 45 | Abnormal EKG (HP:0003115) | 2.86970049 |
| 46 | Primary atrial arrhythmia (HP:0001692) | 2.84085695 |
| 47 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.82946624 |
| 48 | Complement deficiency (HP:0004431) | 2.82001058 |
| 49 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.81287060 |
| 50 | Neck muscle weakness (HP:0000467) | 2.80699677 |
| 51 | Ketosis (HP:0001946) | 2.79693082 |
| 52 | Myopathic facies (HP:0002058) | 2.72840340 |
| 53 | Acute encephalopathy (HP:0006846) | 2.72387464 |
| 54 | Acute necrotizing encephalopathy (HP:0006965) | 2.72250602 |
| 55 | Supraventricular tachycardia (HP:0004755) | 2.69661718 |
| 56 | Oligomenorrhea (HP:0000876) | 2.68425828 |
| 57 | Supraventricular arrhythmia (HP:0005115) | 2.66511094 |
| 58 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.66171790 |
| 59 | Bundle branch block (HP:0011710) | 2.64176993 |
| 60 | Frequent falls (HP:0002359) | 2.63816342 |
| 61 | EMG: neuropathic changes (HP:0003445) | 2.62271283 |
| 62 | Increased CSF protein (HP:0002922) | 2.62012490 |
| 63 | Difficulty climbing stairs (HP:0003551) | 2.60241044 |
| 64 | Abnormality of alanine metabolism (HP:0010916) | 2.58911789 |
| 65 | Hyperalaninemia (HP:0003348) | 2.58911789 |
| 66 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.58911789 |
| 67 | Hepatocellular necrosis (HP:0001404) | 2.57586948 |
| 68 | Facial diplegia (HP:0001349) | 2.53672106 |
| 69 | Hyperammonemia (HP:0001987) | 2.52220633 |
| 70 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.49109826 |
| 71 | Cerebral edema (HP:0002181) | 2.48993871 |
| 72 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.39838060 |
| 73 | Prolonged QT interval (HP:0001657) | 2.39813232 |
| 74 | Heart block (HP:0012722) | 2.34740726 |
| 75 | Lactic acidosis (HP:0003128) | 2.33979878 |
| 76 | Atrioventricular block (HP:0001678) | 2.33915895 |
| 77 | Increased serum pyruvate (HP:0003542) | 2.33459003 |
| 78 | Abnormality of glycolysis (HP:0004366) | 2.33459003 |
| 79 | Increased intramyocellular lipid droplets (HP:0012240) | 2.33282065 |
| 80 | Generalized muscle weakness (HP:0003324) | 2.31930144 |
| 81 | Pheochromocytoma (HP:0002666) | 2.31008035 |
| 82 | Renal cortical cysts (HP:0000803) | 2.30481520 |
| 83 | Progressive macrocephaly (HP:0004481) | 2.29658322 |
| 84 | Ulnar deviation of the wrist (HP:0003049) | 2.27627271 |
| 85 | Skin nodule (HP:0200036) | 2.26909508 |
| 86 | Gowers sign (HP:0003391) | 2.26725727 |
| 87 | Decreased circulating renin level (HP:0003351) | 2.26588408 |
| 88 | Syncope (HP:0001279) | 2.26354026 |
| 89 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.25177259 |
| 90 | Conjunctival hamartoma (HP:0100780) | 2.24041856 |
| 91 | Abnormal atrioventricular conduction (HP:0005150) | 2.23269858 |
| 92 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.21429587 |
| 93 | Hyperlipoproteinemia (HP:0010980) | 2.21401913 |
| 94 | Ventricular arrhythmia (HP:0004308) | 2.21357652 |
| 95 | Nausea (HP:0002018) | 2.20601794 |
| 96 | Proximal tubulopathy (HP:0000114) | 2.17837127 |
| 97 | Malnutrition (HP:0004395) | 2.15759960 |
| 98 | Increased CSF lactate (HP:0002490) | 2.15222619 |
| 99 | Mitochondrial inheritance (HP:0001427) | 2.11100239 |
| 100 | Exercise intolerance (HP:0003546) | 2.10870739 |
| 101 | Areflexia of lower limbs (HP:0002522) | 2.10647663 |
| 102 | Xanthomatosis (HP:0000991) | 2.08595964 |
| 103 | Hypoplastic ischia (HP:0003175) | 2.08475779 |
| 104 | Distal lower limb muscle weakness (HP:0009053) | 2.07818854 |
| 105 | Abnormality of complement system (HP:0005339) | 2.07785039 |
| 106 | Methylmalonic aciduria (HP:0012120) | 2.06420325 |
| 107 | Respiratory failure (HP:0002878) | 2.05742057 |
| 108 | Hyperglycemia (HP:0003074) | 2.03410383 |
| 109 | Rimmed vacuoles (HP:0003805) | 2.02963701 |
| 110 | Neuroendocrine neoplasm (HP:0100634) | 1.98067360 |
| 111 | Muscular dystrophy (HP:0003560) | 1.98030349 |
| 112 | Hyperkalemia (HP:0002153) | 1.97894908 |
| 113 | Acanthosis nigricans (HP:0000956) | 1.97358990 |
| 114 | Left ventricular hypertrophy (HP:0001712) | 1.96729425 |
| 115 | Hypoalphalipoproteinemia (HP:0003233) | 1.96422373 |
| 116 | Hydroxyprolinuria (HP:0003080) | 1.96325383 |
| 117 | Blue irides (HP:0000635) | 1.95660434 |
| 118 | Double outlet right ventricle (HP:0001719) | 1.94010244 |
| 119 | Congenital malformation of the right heart (HP:0011723) | 1.94010244 |
| 120 | Late onset (HP:0003584) | 1.93064447 |
| 121 | Sudden cardiac death (HP:0001645) | 1.92472131 |
| 122 | Vascular calcification (HP:0004934) | 1.90416464 |
| 123 | Growth hormone excess (HP:0000845) | 1.87315533 |
| 124 | Mitral stenosis (HP:0001718) | 1.84728619 |
| 125 | Abnormality of vitamin metabolism (HP:0100508) | 1.84579036 |
| 126 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.80701221 |
| 127 | Cardiovascular calcification (HP:0011915) | 1.73015899 |
| 128 | Abnormality of the foot musculature (HP:0001436) | 1.72694245 |
| 129 | Glomerulonephritis (HP:0000099) | 1.72070826 |
| 130 | Ragged-red muscle fibers (HP:0003200) | 1.72033441 |
| 131 | Bulbar palsy (HP:0001283) | 1.71717038 |
| 132 | Stroke (HP:0001297) | 1.70593702 |
| 133 | Striae distensae (HP:0001065) | 1.70585533 |
| 134 | Steatorrhea (HP:0002570) | 1.69381620 |
| 135 | Bradycardia (HP:0001662) | 1.68679788 |
| 136 | Mucopolysacchariduria (HP:0008155) | 1.67941338 |
| 137 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.67941338 |
| 138 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.67196940 |
| 139 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.67196940 |
| 140 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.67196940 |
| 141 | Hypercortisolism (HP:0001578) | 1.64802437 |
| 142 | Systemic lupus erythematosus (HP:0002725) | 1.64526467 |
| 143 | Congenital sensorineural hearing impairment (HP:0008527) | 1.63262354 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 4.90234900 |
| 2 | TTN | 4.89056365 |
| 3 | PDK3 | 4.45485233 |
| 4 | PDK4 | 4.45485233 |
| 5 | PHKG2 | 3.86218291 |
| 6 | PHKG1 | 3.86218291 |
| 7 | BCKDK | 3.78927321 |
| 8 | TRIB3 | 3.53297520 |
| 9 | PDK2 | 3.04682253 |
| 10 | FRK | 2.78038180 |
| 11 | AKT3 | 2.18358026 |
| 12 | PIK3CG | 2.18192910 |
| 13 | PINK1 | 2.12724567 |
| 14 | DMPK | 2.07298018 |
| 15 | CAMK1D | 1.95095169 |
| 16 | LMTK2 | 1.90109023 |
| 17 | PIK3CA | 1.86610765 |
| 18 | INSRR | 1.73667340 |
| 19 | TIE1 | 1.66527183 |
| 20 | MAP2K6 | 1.65969635 |
| 21 | MUSK | 1.65355019 |
| 22 | CAMK1G | 1.57820707 |
| 23 | PRKAA2 | 1.57340714 |
| 24 | MYLK | 1.47146243 |
| 25 | PKN2 | 1.40882094 |
| 26 | SIK1 | 1.40855339 |
| 27 | FGFR3 | 1.40586537 |
| 28 | NME1 | 1.37306586 |
| 29 | ACVR1B | 1.30528295 |
| 30 | DAPK2 | 1.23519689 |
| 31 | NTRK3 | 1.22045665 |
| 32 | MAP3K7 | 1.20596630 |
| 33 | EPHB1 | 1.12510920 |
| 34 | WNK4 | 1.11091061 |
| 35 | NLK | 1.09620131 |
| 36 | MAPK12 | 1.09381107 |
| 37 | PRKAA1 | 1.08700242 |
| 38 | NEK1 | 1.07408705 |
| 39 | MAP2K3 | 1.05631577 |
| 40 | UHMK1 | 1.03146446 |
| 41 | GRK1 | 1.02448134 |
| 42 | STK39 | 0.96701562 |
| 43 | PRKD1 | 0.94862904 |
| 44 | STK24 | 0.94844826 |
| 45 | PKN1 | 0.93456629 |
| 46 | FGFR2 | 0.87711137 |
| 47 | SGK2 | 0.84314810 |
| 48 | ILK | 0.83085319 |
| 49 | TGFBR2 | 0.81695160 |
| 50 | PAK3 | 0.81671805 |
| 51 | CAMK2D | 0.81608055 |
| 52 | PDGFRA | 0.80736358 |
| 53 | PDPK1 | 0.80631757 |
| 54 | LATS1 | 0.76626977 |
| 55 | MAPK15 | 0.73194201 |
| 56 | RIPK1 | 0.72624460 |
| 57 | NEK9 | 0.71985546 |
| 58 | STK38L | 0.71731312 |
| 59 | TRPM7 | 0.70414559 |
| 60 | WNK1 | 0.66422515 |
| 61 | MAP3K2 | 0.66111541 |
| 62 | GRK7 | 0.65513157 |
| 63 | PDK1 | 0.57734970 |
| 64 | MARK1 | 0.57025766 |
| 65 | PRKD3 | 0.56481061 |
| 66 | MAPK4 | 0.55091992 |
| 67 | ROCK1 | 0.54831309 |
| 68 | PRKG2 | 0.54677053 |
| 69 | ZAP70 | 0.54198351 |
| 70 | MAP3K1 | 0.53964983 |
| 71 | MAP3K12 | 0.52828689 |
| 72 | ERBB3 | 0.51993010 |
| 73 | BLK | 0.51889629 |
| 74 | MAPKAPK3 | 0.51556961 |
| 75 | CAMK2G | 0.49493427 |
| 76 | MAP3K4 | 0.48040432 |
| 77 | STK4 | 0.47858874 |
| 78 | PRKACG | 0.47644093 |
| 79 | PRKCH | 0.46504662 |
| 80 | YES1 | 0.46215151 |
| 81 | STK11 | 0.44996763 |
| 82 | HIPK2 | 0.43513978 |
| 83 | MAP2K4 | 0.43347194 |
| 84 | MAP2K1 | 0.42650550 |
| 85 | MET | 0.40883494 |
| 86 | ERN1 | 0.40503681 |
| 87 | EEF2K | 0.40451522 |
| 88 | JAK2 | 0.40335256 |
| 89 | RET | 0.39615030 |
| 90 | MAP3K3 | 0.39418233 |
| 91 | PRKACA | 0.39214629 |
| 92 | AKT2 | 0.38108624 |
| 93 | FLT3 | 0.38059325 |
| 94 | EPHA3 | 0.37741613 |
| 95 | ZAK | 0.37560763 |
| 96 | TNK2 | 0.37124414 |
| 97 | CAMK1 | 0.36888898 |
| 98 | CAMK2B | 0.36812630 |
| 99 | MAP3K6 | 0.36533397 |
| 100 | ROCK2 | 0.36483654 |
| 101 | FER | 0.36166926 |
| 102 | MST4 | 0.35290524 |
| 103 | ICK | 0.34962781 |
| 104 | RPS6KA3 | 0.34768900 |
| 105 | WNK3 | 0.34611750 |
| 106 | GSK3A | 0.34222247 |
| 107 | CAMK2A | 0.33257438 |
| 108 | PRKACB | 0.32908534 |
| 109 | PTK6 | 0.32610983 |
| 110 | JAK1 | 0.31902808 |
| 111 | PTK2B | 0.31455452 |
| 112 | MAPK11 | 0.31323616 |
| 113 | EPHB2 | 0.30364903 |
| 114 | FGFR4 | 0.30031260 |
| 115 | SGK1 | 0.29762118 |
| 116 | MTOR | 0.29336823 |
| 117 | STK38 | 0.29019448 |
| 118 | PRKCE | 0.27418345 |
| 119 | MST1R | 0.26778969 |
| 120 | LATS2 | 0.26707192 |
| 121 | SGK223 | 0.26560886 |
| 122 | SGK494 | 0.26560886 |
| 123 | CDK9 | 0.26356687 |
| 124 | PRKD2 | 0.26329779 |
| 125 | PAK6 | 0.25814898 |
| 126 | SGK3 | 0.25342982 |
| 127 | PDGFRB | 0.25318500 |
| 128 | CAMK4 | 0.23967358 |
| 129 | PRKG1 | 0.23580778 |
| 130 | MAP3K5 | 0.23450095 |
| 131 | MAPK7 | 0.22693354 |
| 132 | OXSR1 | 0.21886727 |
| 133 | CDC42BPA | 0.20701584 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 6.08476244 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 4.73705221 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.88396861 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.80491068 |
| 5 | Fatty acid metabolism_Homo sapiens_hsa01212 | 3.56472023 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.47430903 |
| 7 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.66461275 |
| 8 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.59079817 |
| 9 | Carbon metabolism_Homo sapiens_hsa01200 | 2.48166209 |
| 10 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.36721708 |
| 11 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.29917057 |
| 12 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.29347150 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.14843462 |
| 14 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.06863484 |
| 15 | Parkinsons disease_Homo sapiens_hsa05012 | 2.02142211 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.89496517 |
| 17 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.89027016 |
| 18 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.88977066 |
| 19 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.76759774 |
| 20 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.70365340 |
| 21 | Alzheimers disease_Homo sapiens_hsa05010 | 1.61685426 |
| 22 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.61383264 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.59477007 |
| 24 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.56053555 |
| 25 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.43402818 |
| 26 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.41518858 |
| 27 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.40584990 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.37531667 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.27095234 |
| 30 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.26960168 |
| 31 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.22080389 |
| 32 | Huntingtons disease_Homo sapiens_hsa05016 | 1.21273737 |
| 33 | Insulin resistance_Homo sapiens_hsa04931 | 1.18586900 |
| 34 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.17254049 |
| 35 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.16241371 |
| 36 | Peroxisome_Homo sapiens_hsa04146 | 1.15987786 |
| 37 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.13741832 |
| 38 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.10204039 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.10026236 |
| 40 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.03741075 |
| 41 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.02417495 |
| 42 | Retinol metabolism_Homo sapiens_hsa00830 | 0.99379707 |
| 43 | Mineral absorption_Homo sapiens_hsa04978 | 0.98524209 |
| 44 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.98449433 |
| 45 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.95514599 |
| 46 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.93147581 |
| 47 | Other glycan degradation_Homo sapiens_hsa00511 | 0.90094796 |
| 48 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.85870298 |
| 49 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.84003227 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.83407179 |
| 51 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.78882104 |
| 52 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.78776592 |
| 53 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.76697830 |
| 54 | Lysine degradation_Homo sapiens_hsa00310 | 0.75762733 |
| 55 | Circadian entrainment_Homo sapiens_hsa04713 | 0.74545800 |
| 56 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.74384277 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.71229792 |
| 58 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.68000720 |
| 59 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.65893383 |
| 60 | Viral myocarditis_Homo sapiens_hsa05416 | 0.63540970 |
| 61 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.63535364 |
| 62 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.61905496 |
| 63 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.61314540 |
| 64 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.61089209 |
| 65 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.59618118 |
| 66 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.59303833 |
| 67 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.57443080 |
| 68 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.55304511 |
| 69 | Renin secretion_Homo sapiens_hsa04924 | 0.55105253 |
| 70 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.52909895 |
| 71 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52112580 |
| 72 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.50834054 |
| 73 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.50393217 |
| 74 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.49205185 |
| 75 | Circadian rhythm_Homo sapiens_hsa04710 | 0.48868942 |
| 76 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.48473698 |
| 77 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.47505894 |
| 78 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.46733048 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.45315542 |
| 80 | GABAergic synapse_Homo sapiens_hsa04727 | 0.45250055 |
| 81 | Focal adhesion_Homo sapiens_hsa04510 | 0.43637441 |
| 82 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.43571778 |
| 83 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.43185966 |
| 84 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.43088564 |
| 85 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.42865751 |
| 86 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.41174138 |
| 87 | Lysosome_Homo sapiens_hsa04142 | 0.40456263 |
| 88 | Galactose metabolism_Homo sapiens_hsa00052 | 0.39924658 |
| 89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.36136475 |
| 90 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36087465 |
| 91 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.34327813 |
| 92 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32897286 |
| 93 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.32814697 |
| 94 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.32560624 |
| 95 | Tight junction_Homo sapiens_hsa04530 | 0.31697563 |
| 96 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.30708010 |
| 97 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.29517717 |
| 98 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.25552944 |
| 99 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.25258464 |
| 100 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.24723137 |
| 101 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.23111893 |
| 102 | Insulin secretion_Homo sapiens_hsa04911 | 0.22734586 |
| 103 | ABC transporters_Homo sapiens_hsa02010 | 0.22537393 |
| 104 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.21999298 |
| 105 | Bile secretion_Homo sapiens_hsa04976 | 0.21613559 |
| 106 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.20953012 |
| 107 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.20107427 |
| 108 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.20071637 |
| 109 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.18309472 |
| 110 | Amoebiasis_Homo sapiens_hsa05146 | 0.14668839 |
| 111 | Salivary secretion_Homo sapiens_hsa04970 | 0.14024193 |
| 112 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.13930612 |
| 113 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.11575549 |
| 114 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.09618745 |
| 115 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.09320826 |
| 116 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.08461927 |
| 117 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.05242330 |
| 118 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.04663768 |
| 119 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.04115244 |
| 120 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.04056558 |
| 121 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.03839652 |
| 122 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.03451809 |
| 123 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.03296945 |
| 124 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.02764465 |
| 125 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.02726565 |
| 126 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.02090982 |
| 127 | Platelet activation_Homo sapiens_hsa04611 | 0.01961163 |
| 128 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.01614535 |

